Yes, columnist Ben Hofmeister has MS, but he'd like to be remembered for something other than his disability or mobility devices.

After a single dose of equecabtagene autoleucel, three people with progressive MS saw benefits, including improved walking ...

Columnist Desiree Lama pens an open letter to her present-day self, who is in need of some support and encouragement while ...

An unexpected relapse has columnist Ahna Crum contemplating what remains when the miracle of stem cell transplant seems ...

The first person with multiple sclerosis was imaged in a clinical trial of a PET tracer to track myelin changes.

In people with benign MS, there is a loss of overall brain tissue but other parts of the brain may grow to help compensate ...

Soon after initiating gender-affirming hormone therapy, seven of 10 adults with MS showed new signs of disease activity on ...

An experimental medication boosted motor function in mice and primate models of multiple sclerosis by repairing the myelin ...

People who develop MS at a younger age tend to have better long-term physical health but worse mental health than those ...

Dosing began at Weill Cornell Medical Center in a Phase 2a trial testing foralumab nasal spray in people with nonactive SPMS.

Columnist Desiree Lama misses the summers when she wasn't dealing with MS and its associated heat intolerance.

Dr. Susan Payrovi and Dr. Mirla Avila have an in-depth discussion around treating MS, and considerations when selecting an MS ...